VentriPoint Diagnostics Ltd.
VPT.V
TSX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -39.96% | 39.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -35.50% | 32.04% | |||
| Operating Income | 44.46% | -43.16% | |||
| Income Before Tax | 41.38% | -39.26% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 41.38% | -39.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 41.38% | -39.26% | |||
| EBIT | 44.46% | -43.16% | |||
| EBITDA | 44.48% | -43.18% | |||
| EPS Basic | 42.11% | -39.02% | |||
| Normalized Basic EPS | 41.67% | -38.46% | |||
| EPS Diluted | 42.11% | -39.02% | |||
| Normalized Diluted EPS | 41.67% | -38.46% | |||
| Average Basic Shares Outstanding | 2.17% | 0.70% | |||
| Average Diluted Shares Outstanding | 2.17% | 0.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||